• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ATL results dip due to HDI 5000 intro

Article

HDI 5000 may represent the future for ATL Ultrasound, but expenses associated with the rollout of the new super-premium ultrasound scanner had a negative impact on the Bothell, WA, company's financial results for the third quarter (end-September). Still,

HDI 5000 may represent the future for ATL Ultrasound, but expenses associated with the rollout of the new super-premium ultrasound scanner had a negative impact on the Bothell, WA, company's financial results for the third quarter (end-September). Still, ATL executives say HDI 5000 is off to a roaring start, with deliveries scheduled for this quarter.

ATL had revenues of $93 million for the third quarter, down 7% compared with sales of $100.3 million in the third quarter of 1996. The firm's net loss for the most recent period was $2 million, compared with net income of $3.8 million in the same quarter a year ago.

ATL attributed the lower revenues to delays in customer order placement that followed HDI 5000's introduction in July, while expenses rose as the company readied the product for market (SCAN 8/6/97). Revenues and gross margin were also affected by the higher dollar, which negatively impacted the company's international business.

In other ATL news, the company announced last week that it has released a radiology version of its Tissue Harmonic Imaging technique, which previously had been available only for cardiology applications. The technique is available on the company's HDI 3000 scanner and will be offered on HDI 5000 when it begins shipping.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.